Published in Ophthalmol Ther on April 08, 2017
Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47
Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol (1998) 5.64
A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol (2002) 5.57
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology (2000) 5.18
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Age-related macular degeneration. Lancet (2012) 4.17
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology (2007) 3.96
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA (2013) 3.53
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Clinical classification of age-related macular degeneration. Ophthalmology (2013) 2.92
Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol (2006) 2.80
The psychosocial impact of macular degeneration. Arch Ophthalmol (1998) 2.79
Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol (2006) 2.77
Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells (2009) 2.70
The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (2003) 2.49
Outer retinal tubulation: a novel optical coherence tomography finding. Arch Ophthalmol (2009) 2.22
Dietary fat and age-related maculopathy. Arch Ophthalmol (1995) 2.11
WEDGE-SHAPED SUBRETINAL HYPOREFLECTIVITY IN GEOGRAPHIC ATROPHY. Retina (2015) 2.05
High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 2.03
Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci (2002) 1.97
Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci (2001) 1.93
Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol (2002) 1.87
The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology (2007) 1.63
Quality of life with macular degeneration: perceptions of patients, clinicians, and community members. Br J Ophthalmol (2003) 1.57
Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol (2002) 1.55
Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology (2014) 1.47
Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.47
Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol (2010) 1.42
Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci (2006) 1.34
Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives. Retina (2010) 1.33
14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology (2005) 1.15
In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.00
Dietary factors and epigenetic regulation for prostate cancer prevention. Adv Nutr (2011) 1.00
Effect of Viagra on the foveolar choroidal circulation of AMD patients. Exp Eye Res (2005) 0.97
Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations. Ophthalmology (2013) 0.94
Prevalence of age-related macular degeneration in elderly Caucasians: the Tromsø Eye Study. Ophthalmology (2012) 0.92
Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects. Clin Ophthalmol (2015) 0.91
Retinal pseudocysts in age-related geographic atrophy. Am J Ophthalmol (2010) 0.88
Optical Coherence Tomography Angiography of Dry Age-Related Macular Degeneration. Dev Ophthalmol (2016) 0.87
Visual impairment and the incidence of falls and fractures among older people: longitudinal findings from the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci (2014) 0.86
The relationship of major American dietary patterns to age-related macular degeneration. Am J Ophthalmol (2014) 0.85
Generation of retinal pigment epithelial cells from human embryonic stem cell-derived spherical neural masses. Stem Cell Res (2012) 0.84
Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study. Am J Clin Nutr (2016) 0.81
Effect of systemic moxaverine on ocular blood flow in humans. Acta Ophthalmol (2008) 0.80
Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial. Expert Opin Investig Drugs (2013) 0.78
Choroidal Caverns: A Novel Optical Coherence Tomography Finding in Geographic Atrophy. Invest Ophthalmol Vis Sci (2016) 0.77
Choroidal Round Hyporeflectivities in Geographic Atrophy. PLoS One (2016) 0.75
Optical Coherence Tomography Angiography: A Useful Tool for Diagnosis of Treatment-Naïve Quiescent Choroidal Neovascularization. Am J Ophthalmol (2016) 0.80
Optical coherence tomography angiography of myopic choroidal neovascularisation. Br J Ophthalmol (2016) 0.76
Recent advances in the management of dry age-related macular degeneration: A review. F1000Res (2017) 0.75
Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation. Br J Ophthalmol (2016) 0.75
Choroidal Round Hyporeflectivities in Geographic Atrophy. PLoS One (2016) 0.75
Swept-source optical coherence tomography angiography in serpiginous choroiditis. Br J Ophthalmol (2017) 0.75
Optical Coherence Tomography Angiography in the Evaluation of Geographic Atrophy Area Extension. Invest Ophthalmol Vis Sci (2017) 0.75
The Expanded Spectrum of Perifoveal Exudative Vascular Anomalous Complex. Am J Ophthalmol (2017) 0.75